According to the European Medicines Agency (EMA), there is no association between any of the versions of the human papillomavirus (HPV) vaccine and two syndromes that lay reports and documentation in medical literature have suggested may be connected to it, Medscape reports. The EMA’s Pharmacovigilance Risk Assessment Committee  conducted a review of evidence surrounding reports of two syndromes, complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS), developing following HPV vaccination.

The committee found no connection between the vaccine and CRPS or POTS, and consequently said that no changes should be made to the way the vaccines are used, nor should adjustments be made to their product information. The scientists found that rate of development of CRPS and POTS following HPV vaccination was consistent with what would normally be seen in this age group. Both of these rare syndromes develop among the general population, including adolescents, whether they are vaccinated or not.

To read the Medscape article, click here.